Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial

被引：0
|
作者：
Paller, Amy [1 ]
Hebert, Adelaide A. [2 ,3 ]
Jett, John E. [4 ]
Brown, Philip M. [4 ]
Rubenstein, David S. [4 ]
Piscitelli, Stephen C. [4 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] UTHlth McGovern Med Sch, Houston, TX USA
[3] Childrens Mem Hermann Hosp, Houston, TX USA
[4] Dermavant Sci Inc, Morrisville, NC USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
D O I：
10.1093/bjd/ljac140.005
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
301
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: outcomes from the 4-week maximal usage trial
    Paller, Amy
    Jett, John E.
    Hebert, Adelaide
    Brown, Philip M.
    Butners, Victoria
    Fitzgerald, Nancy
    Delgado, Marta
    Gonzalez, Mercedes E.
    Piscitelli, Stephen C.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials
    Gold, Linda Stein
    Del Rosso, James
    Ehst, Benjamin D.
    Zirwas, Matthew J.
    Green, Lawrence J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Tallman, Anna M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [3] Tapinarof cream 1% once daily for the treatment of moderate-to-severe atopic dermatitis in children and adults: the pivotal phase III ADORING clinical program
    Eichenfield, L. F.
    Silverberg, J. I.
    Bissonnette, R.
    Tallman, A. M.
    Brown, P. M.
    Rubenstein, D. S.
    Piscitelli, S. C.
    Jett, J. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E136 - E136
  • [4] Tapinarof cream 1% once daily for the treatment of moderate-to-severe atopic dermatitis in children and adults: the pivotal phase III ADORING clinical programme
    Eichenfield, L. F.
    Silverberg, J. I.
    Bissonnette, R.
    Tallman, A. M.
    Brown, P. M.
    Rubenstein, D. S.
    Piscitelli, S. C.
    Jett, J. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E127 - E128
  • [5] Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
    Jett, John E.
    McLaughlin, Michael
    Lee, Mark S.
    Parish, Lawrence Charles
    DuBois, Janet
    Raoof, Tooraj Joseph
    Tabolt, Glenn
    Wilson, Timothy
    Somerville, Matthew C.
    DellaMaestra, Wayne
    Piscitelli, Stephen C.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (01) : 83 - 91
  • [6] Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics
    John E. Jett
    Michael McLaughlin
    Mark S. Lee
    Lawrence Charles Parish
    Janet DuBois
    Tooraj Joseph Raoof
    Glenn Tabolt
    Timothy Wilson
    Matthew C. Somerville
    Wayne DellaMaestra
    Stephen C. Piscitelli
    American Journal of Clinical Dermatology, 2022, 23 : 83 - 91
  • [7] Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream
    Tschen, E
    Elewski, B
    Gorsulowsky, DC
    Pariser, DM
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) : S9 - S14
  • [8] Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II17 - II18
  • [9] Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2-11 years: 52 week results from a maximum-use trial
    Bissonnette, Robert
    Lee, Mark S.
    Forman, Seth B.
    Gold, Linda Stein
    Kallender, Howard
    Angel, Brett
    Kuo, Yutzu
    Paller, Amy S.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [10] Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials
    Silverberg, Jonathan I.
    Eichenfield, Lawrence F.
    Hebert, Adelaide A.
    Simpson, Eric L.
    Gold, Linda Stein
    Bissonnette, Robert
    Papp, Kim A.
    Browning, John
    Kwong, Pearl
    Korman, Neil J.
    Brown, Philip M.
    Rubenstein, David S.
    Piscitelli, Stephen C.
    Somerville, Matthew C.
    Tallman, Anna M.
    Kircik, Leon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (03) : 457 - 465
12345